News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AWKNF
Recent news which mentions AWKNF
< Previous
1
2
3
Next >
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
Tickers
AWKNF
BETRF
CMND
FLHLF
Tags
PBM
TRUFF
BETRF
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
TRUFF
CYBN
Management
From
Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
January 26, 2024
Tickers
AWKNF
CMND
CMPS
FLHLF
Tags
GHRS
Financing
Psychedelics
From
Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
December 27, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
ENVB
Markets
SEEL
From
Benzinga
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
December 21, 2023
Tickers
AWKNF
Tags
clinical trial
AWKNF
Psychedelics
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Cannabis
PSIL
Market News
From
Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
November 15, 2023
Tickers
AWKNF
CMPS
Tags
Markets
Ketamine/Assisted Therapy
News
From
Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
Tags
Markets
ScholarGPS
Drug Science
From
Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
ENVB
Markets
SEEL
From
Benzinga
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
September 06, 2023
Tickers
AWKNF
Tags
General
Ketamine
Markets
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
Earnings
AGNPF
ATAI
From
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
LSDI
MNMD
PMBHF
From
Benzinga
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
August 01, 2023
Tickers
AWKNF
Tags
Markets
News
Benzinga
From
Benzinga
Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder
July 26, 2023
Tickers
AWKNF
Tags
Market News
Markets
Cannabis
From
Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
July 11, 2023
Tickers
AWKNF
CMPS
DMTTF
FLHLF
Tags
LSDI
FLHLF
PMBHF
From
Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
July 05, 2023
Tickers
AWKNF
Tags
Psychedelics
AWKNF
alcohol use disorder
From
Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
Tags
Markets
News
Financing
From
Benzinga
Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism
June 12, 2023
Tickers
AWKNF
Tags
Markets
News
Global
From
Benzinga
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
May 01, 2023
Tickers
AWKNF
IXHL
MNMD
MSSTF
Tags
LSD
TRUFF
Markets
From
Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
April 28, 2023
Tickers
AWKNF
Tags
Markets
News
Ketamine/Assisted Therapy
From
Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
MNMD
HUGE
Top Stories
From
Benzinga
Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study
April 19, 2023
Tickers
AWKNF
Tags
News
Management
Top Stories
From
Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
April 19, 2023
Tickers
AWKNF
Tags
George McBride
Market News
Nick Kadysh
From
Benzinga
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
April 17, 2023
Tickers
ATAI
AWKNF
CYBN
FLHLF
Tags
Contracts
Cannabis
PSIL
From
Benzinga
Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership
April 14, 2023
Tickers
AWKNF
Tags
New Chemical Entity
News
AWKNF
From
Benzinga
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
March 19, 2023
Tickers
AWKNF
Tags
Cannabis
Market News
Benzinga
From
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
Tickers
ATAI
AWKNF
CYBN
DMTTF
Tags
Markets
Simeon Schnapper
DMTTF
From
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Tickers
AGNPF
AWKNF
BRAXF
CMPS
Tags
News
Psychedelics Reform
BRAXF
From
Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
Tags
News
Psychedelics
AWKNF
From
Benzinga
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
March 02, 2023
Tickers
AWKNF
OPTHF
Tags
OPTHF
Psychedelics
AWKNF
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.